Cargando…
Vaccines, inspiring innovation in health()
This report covers the topics of pandemics, epidemics and partnerships, including regulatory convergence initiatives, new technologies and novel vaccines, discussed by leading public and private sector stakeholders at the 18th Annual General Meeting (AGM) of the Developing Countries Vaccine Manufact...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238075/ https://www.ncbi.nlm.nih.gov/pubmed/29789241 http://dx.doi.org/10.1016/j.vaccine.2018.05.035 |
_version_ | 1783371303021969408 |
---|---|
author | Pagliusi, Sonia Dennehy, Maureen Kim, Hun |
author_facet | Pagliusi, Sonia Dennehy, Maureen Kim, Hun |
author_sort | Pagliusi, Sonia |
collection | PubMed |
description | This report covers the topics of pandemics, epidemics and partnerships, including regulatory convergence initiatives, new technologies and novel vaccines, discussed by leading public and private sector stakeholders at the 18th Annual General Meeting (AGM) of the Developing Countries Vaccine Manufacturers’ Network (DCVMN). Contributions of Gavi and the vaccine industry from emerging countries to the growing global vaccine market, by improving the supply base from manufacturers in developing countries and contributing to 58% of doses, were highlighted. The Coalition for Epidemic Preparedness Innovations (CEPI), the International Vaccine Institute (IVI) and others reported on new strategies to ensure speedy progress in preclinical and clinical development of innovative vaccines for future MERS, Zika or other outbreak response. Priorities for vaccine stockpiling, to assure readiness during emergencies and to prevent outbreaks due to re-emerging diseases such as yellow fever, cholera and poliomyelitis, were outlined. The role of partnerships in improving global vaccine access, procurement and immunization coverage, and shared concerns were reviewed. The World Health Organization (WHO) and other international collaborating partners provided updates on the Product, Price and Procurement database, the prequalification of vaccines, the control of neglected tropical diseases, particularly the new rabies elimination initiative, and regulatory convergence proposals to accelerate vaccine registration in developing countries. Updates on supply chain innovations and novel vaccine platforms were presented. The discussions enabled members and partners to reflect on efficiency of research & development, supply chain tools and trends in packaging technologies improving delivery of existing vaccines, and allowing a deeper understanding of the current public-health objectives, industry financing, and global policies, required to ensure optimal investments, alignment and stability of vaccine supply in developing countries. |
format | Online Article Text |
id | pubmed-6238075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Authors. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62380752018-11-21 Vaccines, inspiring innovation in health() Pagliusi, Sonia Dennehy, Maureen Kim, Hun Vaccine Article This report covers the topics of pandemics, epidemics and partnerships, including regulatory convergence initiatives, new technologies and novel vaccines, discussed by leading public and private sector stakeholders at the 18th Annual General Meeting (AGM) of the Developing Countries Vaccine Manufacturers’ Network (DCVMN). Contributions of Gavi and the vaccine industry from emerging countries to the growing global vaccine market, by improving the supply base from manufacturers in developing countries and contributing to 58% of doses, were highlighted. The Coalition for Epidemic Preparedness Innovations (CEPI), the International Vaccine Institute (IVI) and others reported on new strategies to ensure speedy progress in preclinical and clinical development of innovative vaccines for future MERS, Zika or other outbreak response. Priorities for vaccine stockpiling, to assure readiness during emergencies and to prevent outbreaks due to re-emerging diseases such as yellow fever, cholera and poliomyelitis, were outlined. The role of partnerships in improving global vaccine access, procurement and immunization coverage, and shared concerns were reviewed. The World Health Organization (WHO) and other international collaborating partners provided updates on the Product, Price and Procurement database, the prequalification of vaccines, the control of neglected tropical diseases, particularly the new rabies elimination initiative, and regulatory convergence proposals to accelerate vaccine registration in developing countries. Updates on supply chain innovations and novel vaccine platforms were presented. The discussions enabled members and partners to reflect on efficiency of research & development, supply chain tools and trends in packaging technologies improving delivery of existing vaccines, and allowing a deeper understanding of the current public-health objectives, industry financing, and global policies, required to ensure optimal investments, alignment and stability of vaccine supply in developing countries. The Authors. Published by Elsevier Ltd. 2018-11-19 2018-05-19 /pmc/articles/PMC6238075/ /pubmed/29789241 http://dx.doi.org/10.1016/j.vaccine.2018.05.035 Text en © 2018 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Pagliusi, Sonia Dennehy, Maureen Kim, Hun Vaccines, inspiring innovation in health() |
title | Vaccines, inspiring innovation in health() |
title_full | Vaccines, inspiring innovation in health() |
title_fullStr | Vaccines, inspiring innovation in health() |
title_full_unstemmed | Vaccines, inspiring innovation in health() |
title_short | Vaccines, inspiring innovation in health() |
title_sort | vaccines, inspiring innovation in health() |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238075/ https://www.ncbi.nlm.nih.gov/pubmed/29789241 http://dx.doi.org/10.1016/j.vaccine.2018.05.035 |
work_keys_str_mv | AT pagliusisonia vaccinesinspiringinnovationinhealth AT dennehymaureen vaccinesinspiringinnovationinhealth AT kimhun vaccinesinspiringinnovationinhealth AT vaccinesinspiringinnovationinhealth |